66 reports

  • TYPES OF DEPRESSION
  • CAUSES & SYMPTOMS OF DEPRESSION
  • Depression
  • World
  • AstraZeneca PLC
  • Lundbeck Inc.
  • Pfizer Inc.
  • Depression
  • Strattera is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder....
  • Depression
  • Allergan plc
  • Eli Lilly & Co.
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited

Unipolar Depression: Disease Definition ##.

  • Depression
  • Mental Health
  • Europe
  • World
  • Forecast

Bipolar Depression: Disease Definition ##.

  • Depression
  • Mental Health
  • Europe
  • World
  • Forecast

Major Depression: Disease Definition ##.

  • Depression
  • Mental Health
  • Europe
  • World
  • Forecast
  • 3.1 BIBLIOGRAPHY
  • RISK FACTORS AND COMORBIDITIES FOR MDD

Depression.

  • Depression
  • Japan
  • United States
  • World
  • Forecast

Key Features of the Report: - Depression : Disease Definition - Depression Patient Flow - Depression Prevalence - Depression Diagnosed Patients - Depression Treated Patients

  • Depression
  • Mental Health
  • Europe
  • World
  • Forecast
  • SUBTYPES OF MAJOR DEPRESSIVE DISORDER
  • TREATMENT GUIDELINES FOR MAJOR DEPRESSIVE DISORDER
  • Depression
  • Alkermes plc
  • Allergan plc
  • Lundbeck Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • 07. Disorder Overview
  • 06. Introduction
  • Depression
  • Actavis plc
  • Bristol-Myers Squibb Company
  • Eli Lilly & Co.
  • GlaxoSmithKline plc

Unipolar Depression: Disease Definition ##.

  • Depression
  • Europe
  • France
  • Germany
  • Forecast

Major Depression: Disease Definition ##.

  • Depression
  • Europe
  • France
  • Germany
  • Forecast

Bipolar Depression: Disease Definition ##.

  • Depression
  • Europe
  • France
  • Germany
  • Forecast

It also provides a comprehensive understanding of the emerging Phase III therapies for Bipolar Disorder (Manic Depression) which can turn out to be future prospective competitors for the marketed products.

  • Bipolar Disorder
  • Depression
  • World
  • Demand
  • Product Initiative

Global Depressive Disorder Market DataPack (2016-2020) Types of Depression Causes & Symptoms of Depression Global Depressive Disorder Market by Value (2010-2015) Global Depressive Disorder Market Forecast by Value (2016-2020) Global Depressive Disorder Market by Region (2015) G

  • Depression
  • Mental Health
  • World
  • Forecast
  • GLOBAL INTERNAL NEUROSTIMULATION IN DEPRESSION, BY GEOGRAPHY,
  • 6.4 GLOBAL INTERNAL NEUROSTIMULATION IN DEPRESSION, BY GEOGRAPHY
  • Depression
  • World
  • Boston Scientific Corporation
  • Cyberonics, Inc.
  • EnteroMedics Inc.
  • 07.1 TYPES OF DEPRESSION
  • 07.4 TREATMENT AND MANAGEMENT
  • Depression
  • United States
  • Actavis plc
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • LIBRA DEEP BRAIN STIMULATION SYSTEM - DEPRESSION
  • LIBRA DEEP BRAIN STIMULATION SYSTEM - DEPRESSION - DEEP BRAIN STIMULATION FOR TREATMENT-RESISTANT...
  • Depression
  • United States
  • GlobalData's company
  • Jude Medical, Inc.
  • Thoratec Corporation

Physician Views: Can Lundbeck and Otsuka%s newly approved Rexulti compete with branded and generic competition in the schizophrenia and depression markets?

  • Depression
  • Mental Health
  • Pathology
  • Psychotic Disorder
  • Therapy
  • Small Molecules to Antagonize mGlu2 for Anxiety and Depression
  • Products under Investigation by Universities/Institutes, H2 2017
  • Depression
  • Psychotic Disorder
  • World
  • Product Initiative
  • Addex Therapeutics Ltd
  • Depression
  • Depression
  • Depression
  • Mental Health
  • United States
  • Product Initiative
  • Pfizer Inc.
  • Small Molecules to Antagonize mGlu2 for Anxiety and Depression
  • Products under Investigation by Universities/Institutes, H2 2016
  • Depression
  • Pharmaceutical
  • World
  • Product Initiative
  • Addex Therapeutics Ltd
  • Depression - Discontinued Products
  • (MDD) and postpartum depression (PPD).
  • Depression
  • Mental Health
  • Pharmaceutical
  • Therapy
  • Anavex Life Sciences Corp.
  • SMALL MOLECULES TO ANTAGONIZE NMDA RECEPTOR 2B FOR DEPRESSION AND MAJOR DEPRESSIVE...
  • PIPELINE BY BIOCREA GMBH, H2 2017
  • Depression
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • Treatment Resistant Depression - Product Development Milestones
  • Treatment Resistant Depression - Discontinued Products, H2 2016
  • Depression
  • Therapy
  • United States
  • Product Initiative
  • Avanir Pharmaceuticals, Inc.
  • BIPOLAR II DEPRESSION: LITHIUM, SSRI, OR THE COMBINATION
  • TOP COMPANIES PARTICIPATING IN BIPOLAR DISORDER (MANIC DEPRESSION) THERAPEUTICS CLINICAL...
  • Bipolar Disorder
  • Clinical Trial
  • Depression
  • Neurology
  • World
  • Products under Investigation by Universities/Institutes, H1 2016
  • Metabotropic Glutamate Receptor 2 (mGluR2 or GRM2 or GPRC1B or MGLUR2) - Dormant Projects
  • Depression
  • Therapy
  • World
  • Product Initiative
  • Addex Therapeutics Ltd
  • Bipolar Disorder (Manic Depression) Overview
  • Bipolar Disorder (Manic Depression) - Dormant Projects
  • Depression
  • Mental Health
  • United States
  • Product Initiative
  • Intra-Cellular Therapies, Inc.
  • Treatment Resistant Depression - Product Development Milestones
  • Treatment Resistant Depression - Discontinued Products, H1 2016
  • Depression
  • Therapy
  • United States
  • Product Initiative
  • Avanir Pharmaceuticals, Inc.

The company' s respiratory disease product pipeline includes compounds in various development stages for the treatment of obstructive sleep apnea (OSA), chronic and post-surgical central sleep apnea (CSA), opioid induced respiratory depression, spinal cord injury, and induced respirator

  • Depression
  • Healthcare
  • Pharmaceutical
  • United States
  • RespireRx Pharmaceuticals Inc.
  • Bipolar Disorder (Manic Depression) Overview
  • Bipolar Disorder (Manic Depression) - Recent Pipeline Updates
  • Bipolar Disorder
  • Depression
  • Therapy
  • United States
  • Product Initiative